Actively Recruiting
Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy
Led by Vastra Gotaland Region · Updated on 2026-02-23
459
Participants Needed
1
Research Sites
173 weeks
Total Duration
On this page
Sponsors
V
Vastra Gotaland Region
Lead Sponsor
U
Uppsala University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Magnetic tracer injected before preoperative chemotherapy in breast cancer patients for sentinel lymph node detection. Also, magnetic tracer in combination with magnetic clip for index node identification.
CONDITIONS
Official Title
Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years of age or older.
- Patients with breast cancer planned to undergo neoadjuvant chemotherapy with planned sentinel lymph node dissection or targeted axillary lymph node dissection combined with breast surgery after chemotherapy.
You will not qualify if you...
- Intolerance or hypersensitivity to iron, dextran compounds, or SPIO.
- Patients requiring MRI to evaluate tumor response.
- Pregnancy or breastfeeding.
- Patients with iron overload disease.
- Patients deprived of liberty or under guardianship.
- Inability to understand information, give informed consent, or undergo study procedures.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sahlgrenska University Hospital
Gothenburg, Sweden, 413 45
Actively Recruiting
Research Team
F
Fredrik AM Warnberg, prof
CONTACT
K
Kian AM Chin, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here